A
Here are 10 key points about Rybelsus 7 mg (semaglutide):
1. What it is
Rybelsus 7 mg is an oral prescription medicine for type 2 diabetes, containing semaglutide, a GLP-1 receptor agonist.
2. Main purpose
It helps lower blood sugar levels in adults with type 2 diabetes when diet and exercise alone are not enough.
3. How it works
It works by:
increasing insulin release when blood sugar is high
reducing sugar production in the liver
slowing stomach emptying (helps reduce glucose spikes)
4. Unique feature
It is one of the first GLP-1 drugs taken as a tablet (not injection), usually taken once daily.
5. How to take it
Take first thing in the morning
On an empty stomach
With a small amount of plain water only
Wait at least 30 minutes before eating or other medicines
6. Common side effects
nausea
vomiting
diarrhoea
constipation
abdominal pain
reduced appetite
These often improve over time.
7. Serious risks (rare but important)
pancreatitis
severe allergic reactions
kidney issues (in rare cases)
possible thyroid tumour warning (contraindicated in certain patients)
8. Risk of low blood sugar
Hypoglycaemia can occur, especially if combined with:
insulin
sulfonylureas (e.g., glimepiride, gliclazide)
9. Additional benefits
Besides glucose control, it may also:
promote weight loss
reduce risk of some diabetes complications (heart, kidney, nerve damage)
10. Key precautions
Avoid or use carefully if:
personal/family history of medullary thyroid cancer (MTC)
MEN2 syndrome
history of pancreatitis
Always use under medical supervision.
TAGLINE
A once-daily oral GLP-1 drug that lowers blood sugar, supports weight loss, and works by enhancing the body’s natural insulin response.
No comments:
Post a Comment